Detalles de la búsqueda
1.
Pharmacogenomics in Pediatric Oncology: Mitigating Adverse Drug Reactions While Preserving Efficacy.
Annu Rev Pharmacol Toxicol
; 61: 679-699, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976737
2.
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Annu Rev Pharmacol Toxicol
; 61: 65-84, 2021 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006916
3.
Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?
Genet Med
; 26(2): 101033, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007624
4.
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.
Circulation
; 145(4): 279-294, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874743
5.
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity.
Ther Drug Monit
; 45(3): 337-344, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728273
6.
Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.
Ther Drug Monit
; 45(6): 714-730, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37726872
7.
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children.
Ther Drug Monit
; 45(3): 345-353, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36917731
8.
Noninvasive testing for mycophenolate exposure in children with renal transplant using urinary metabolomics.
Pediatr Transplant
; 27(3): e14460, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36582125
9.
Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries.
Pediatr Nephrol
; 38(2): 593-604, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748941
10.
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
Pediatr Nephrol
; 38(5): 1667-1685, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260162
11.
Optimizing therapeutic decision-making for off-label medicines use: A scoping review and consensus recommendations for improving practice and research.
Pharmacoepidemiol Drug Saf
; 32(11): 1200-1222, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208845
12.
Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services.
Clin Infect Dis
; 75(Suppl 1): S11-S17, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35680552
13.
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
Cancer
; 128(1): 169-179, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34490624
14.
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis C.
Liver Int
; 42(4): 796-808, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35107877
15.
Paediatric oral formulations: Why don't our kids have the medicines they need?
Br J Clin Pharmacol
; 88(10): 4337-4348, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803881
16.
Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
Br J Clin Pharmacol
; 88(10): 4297-4310, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907575
17.
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine.
Pharmacoepidemiol Drug Saf
; 30(8): 985-992, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33715268
18.
COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials.
Can J Physiol Pharmacol
; 99(6): 577-588, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852809
19.
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.
Pharmacogenomics J
; 20(2): 306-319, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31673144
20.
Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization.
Pharmacogenomics J
; 20(5): 746, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32704026